Time and Financial Toxicity Implications during Consideration of Pembrolizumab Infusion Frequency
Autor: | Nori, S., Strohbehn, G., Bryant, A.K. |
---|---|
Zdroj: | In International Journal of Radiation Oncology, Biology, Physics 1 October 2024 120(2) Supplement:e778-e778 |
Databáze: | ScienceDirect |
Externí odkaz: |